Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Dec 8;323(7325):1340-3.
doi: 10.1136/bmj.323.7325.1340.

Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice

A G Zermansky  1 , D R Petty, D K Raynor, N Freemantle, A Vail, C J Lowe
Affiliations
Clinical Trial

Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice

A G Zermansky et al. BMJ. .

Abstract

Objective: To determine whether a pharmacist can effectively review repeat prescriptions through consultations with elderly patients in general practice.

Design: Randomised controlled trial of clinical medication review by a pharmacist against normal general practice review.

Setting: Four general practices.

Participants: 1188 patients aged 65 or over who were receiving at least one repeat prescription and living in the community.

Intervention: Patients were invited to a consultation at which the pharmacist reviewed their medical conditions and current treatment.

Main outcome measures: Number of changes to repeat prescriptions over one year, drug costs, and use of healthcare services.

Results: 590 (97%) patients in the intervention group were reviewed compared with 233 (44%) in the control group. Patients seen by the pharmacist were more likely to have changes made to their repeat prescriptions (mean number of changes per patient 2.2 v 1.9; difference=0.31, 95% confidence interval 0.06 to 0.57; P=0.02). Monthly drug costs rose in both groups over the year, but the rise was less in the intervention group (mean difference 4.72 pound sterling per 28 days, - 7.04 pound sterling to - 2.41 pound sterling); equivalent to 61 pound sterling per patient a year. Intervention patients had a smaller rise in the number of drugs prescribed (0.2 v 0.4; mean difference -0.2, -0.4 to -0.1). There was no evidence that review of treatment by the pharmacist affected practice consultation rates, outpatient consultations, hospital admissions, or death rate.

Conclusions: A clinical pharmacist can conduct effective consultations with elderly patients in general practice to review their drugs. Such review results in significant changes in patients' drugs and saves more than the cost of the intervention without affecting the workload of general practitioners.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Process for reviewing repeat prescriptions
Figure 2
Figure 2
Randomisation of patients and reasons for exclusion from final analysis
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Harris CM, Dajda R. The scale of repeat prescribing. Br J Gen Pract. 1996;46:649–653. - PMC - PubMed
    1. Zermansky AG. Who controls repeats? Br J Gen Pract. 1996;46:643–647. - PMC - PubMed
    1. Audit Commission. A prescription for improvement. Towards more rational prescribing in general practice. London: HMSO; 1994.
    1. Purves I, Kennedy J. The quality of general practice repeat prescribing. Newcastle: University of Newcastle upon Tyne; 1994.
    1. Royal College of Physicians. Medication for older people. 2nd ed. London: RCP; 1997. - PMC - PubMed

Publication types